期刊文献+

MicroRNA对药物转运体调控作用的研究进展

Development of microRNA-dependment control of drug transporter
下载PDF
导出
摘要 MicroRNA作为一类单链非编码小分子RNA,通过与靶基因mRNA 3'端非编码区(3'-untranslated region,3'-UTR)的互补结合来调节靶基因的表达,在生物发育、细胞分化、增殖和凋亡中发挥重要作用,与人类多种疾病如恶性肿瘤、糖尿病等的发生发展密切相关。MicroRNA表达的变化可影响药物代谢酶和转运体的表达,进而影响药物效应。目前有关药物代谢酶的研究较为深入,而对转运体的研究则相对较少。本文通过总结近几年国内外相关研究,从MicroRNA的作用机制及其对药物转运体的调控作用方面进行综述,以期为指导临床个体化用药提供理论依据。 MicroRNA is a class of small noncoding single-stranded molecule RNA, regulating the expression of target genes though com- plementary binding with the target gene mRNA 3'untranslated region (3'-untranslated region, 3' UTR) and plays an important role in biology developmental, cell differentiation, proliferation and apoptosis. And it closely related to the occurrence and development with many human diseases such as cancer, diabetes and so on. Drugmetabolizing enzymes and transporters expression can be affected by the changes of MicroRNA expression, thereby affecting drug effect.Current researches on drug metabolizing enzymes are more in-depth, while the transporters are relatively small. This paper summarizes research at home and abroad in recent years, the mechanism of action about MicroRNA and its regulation about drug transporter were reviewed. So as to provide a theoretical basis to guide the clinical individualized medicine.
出处 《中国临床药理学与治疗学》 CAS CSCD 2014年第9期1064-1068,共5页 Chinese Journal of Clinical Pharmacology and Therapeutics
基金 国家自然科学基金(81373476) 中南大学自主探索创新基金(2014zzts314) 国家重大新药创制科技重大专项基金资助项目(2012ZX0903014-001)
关键词 MICRORNA 转运体 调控作用 MicroRNA transporters regulation
  • 相关文献

参考文献37

  • 1Glubb DM, Innocenti F. Mechanisms of genetic regulation in gene expression: examples from drug metabolizing enzymes and transporters [J]. Wiley Interdiscip Rev Syst Biol Med. , 2011, 3(3): 299- 313.
  • 2郭瑜,周宏灏,刘昭前.miRNA与药物反应个体差异[J].中国临床药理学与治疗学,2013,18(4):443-448. 被引量:5
  • 3Bartel DP. MieroRNAs.. target recognition and reg- ulatory functions[J]. Cell, 2009, 136(2): 215-233.
  • 4Toscano-Garibay JD, Aquino-Jarquin G. Regulation exerted by miRNAs in the promoter and UTR se- quences: MDR1/P-gp expression as a particular case[J]. DNA Cell Biol, 2012, 31(8):1358-1364.
  • 5Shukla GC, Singh J, Barik S. MicroRNAs: pro- cessing, maturation, target recognition and regula- tory functions[J]. Mol Cell Pharmacol, 2011, 3 (3) : 83.
  • 6Lim LP, Lau NC, Garrett-Engele P, et al. Mi- croarray analysis shows that some microRNAs downregulate large numbers of target mRNAs[J]. Nature, 2005, 433: 769-773.
  • 7Ho RH, Kim RB. Transporters and drug therapy: implications for drug disposition and disease [ J ]. Clin Pharmacol Ther, 2005, 78(3): 260-277.
  • 8马丁.卵巢癌多药耐药机制的探讨[J].中华妇幼临床医学杂志(电子版),2007,3(4):184-188. 被引量:6
  • 9Zhu H, Wu H, Liu X, et al. Role of MicroRNA miR-27a and miR-451 in the regulation of MDR1/P- glyeoprotein expression in human cancer cells[J]. Bioehem Pharmaeol, 2008, 76(5): 582-588.
  • 10Li Z, Hu S, Wang J, et al. MiR-27a modulates MDR1/P-glycoprotein expression by targeting HIPK2 in human ovarian cancer cells[J]. Gynecol Oncol, 2010, 119(1): 125-130.

二级参考文献3

  • 1Xiaokui Yang,Fang Zheng,Hui Xing,Qinglei Gao,Wang Wei,Yunping Lu,Shixuan Wang,Jianfeng Zhou,Wei Hu,Ding Ma. Resistance to chemotherapy-induced apoptosis via decreased caspase-3 activity and overexpression of antiapoptotic proteins in ovarian cancer[J] 2004,Journal of Cancer Research and Clinical Oncology(7):423~428
  • 2Refika I. Pakunlu,Thomas J. Cook,Tamara Minko. Simultaneous Modulation of Multidrug Resistance and Antiapoptotic Cellular Defense by MDR1 and BCL-2 Targeted Antisense Oligonucleotides Enhances the Anticancer Efficacy of Doxorubicin[J] 2003,Pharmaceutical Research(3):351~359
  • 3Hu, ZB Chen, X Zhao, Y Tian, T Jin, GF Shu, YQ Chen, YJ Xu, L Zen, K Zhang, CY Shen, HB.Serum MicroRNA Signatures Identified in a Genome-Wide Serum MicroRNA Expression Profiling Predict Survival of Non-Small-Cell Lung Cancer(摘要)[J].南京医科大学学报(自然科学版),2010,30(7):1030-1030. 被引量:141

共引文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部